Navigation Links
GlaxoSmithKline Accelerates Review of Exelixis' XL880
Date:8/23/2007

XL880 has attractive pharmaceutical properties, with high solubility and oral bioavailability. In preclinical studies, XL880 inhibited its targets with nanomolar potency, and retained potent activity against mutationally activated forms of MET found in hereditary papillary renal cell carcinomas. The compound also demonstrated dose-dependent tumor growth inhibition in models of breast cancer, colorectal cancer, non-small cell lung cancer, and glioblastoma, and has been shown to cause substantial tumor regression in all models tested. Significantly, a single dose of XL880 completely inhibited tumor growth for 21 days in a glioblastoma model.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in Phase 2 and Phase 1 clinical development for cancer and renal disease. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GSK, Bristol-Myers Squibb, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com.

This press release contains forward-looking statements, including, without limitation, statements related to the future development and potential efficacy of XL880 and the timing of the submission of XL880 to GSK. Words such as "expects," "will," "expedite," "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Exelixis' current expectations. Forward-looking statements involve risks and u
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GlaxoSmithKline and Genmab Present Positive Phase II Results With ofatumumab in Patients With Rheumatoid Arthritis (RA)
2. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
3. New Data on Genmab and GlaxoSmithKlines Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
6. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
7. Medicures MEND-CABG Trial Results Published in Peer Reviewed Journal
8. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
9. Salix Pharmaceuticals Previews Digestive Disease Week 2007
10. Reatas Synthetic Triterpenoids Profiled in Nature Reviews Cancer
11. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... at two upcoming investor conferences.  , 31 st ... on Tuesday, December 2, 2014 at 6:45 a.m. EST / 11:45 ... of EUSA International, will provide an overview of the company and ... Piper Jaffray Healthcare Conference in New York, NY ...
(Date:11/24/2014)... ATLANTA , Nov. 24, 2014  CryoLife, Inc. (NYSE: ... processing company focused on cardiac and vascular surgery, announced today ... Annual Piper Jaffray Healthcare Conference on Wednesday, December 3, 2014 ... York City . A live webcast of ... ET and will feature an overview of the company by ...
(Date:11/24/2014)... BOCA RATON, Fla. , Nov. 24, 2014  Marta ... Aesthetic Medicine, Boca Raton , FL and international ... dermatologic physicians selected from the United States ... 14-16 in Istanbul, Turkey . Here, at ... truly meet West, as world renowned facial plastic surgery experts ...
Breaking Medicine Technology:Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3
... Conn., Dec. 9, 2010 Boehringer Ingelheim Pharmaceuticals, Inc. ... the phase IIb/III LUX-Lung 1 trial show that afatinib ... 1.0 month for placebo) in progression-free survival (PFS) in ... to have an epidermal growth factor receptor (EGFR) mutation.(1) ...
... 8, 2010 Dr. Richard Merkin, President and CEO, Heritage ... Bears with Liz Clayman and David Asman revealing HPN,s new ... hospital health care costs. "We want in on ... she introduced Dr. Merkin. The HPN Health Prize ...
Cached Medicine Technology:New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 2New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 3New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 4New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 5Dr. Richard Merkin, President and CEO, Heritage Provider Network, Featured on Fox Business News, Bulls and Bears with Liz Clayman and David Asman, Revealing Challenge of $3 Million HPN Health Prize, Saving $30 Billion in Health Care Costs 2Dr. Richard Merkin, President and CEO, Heritage Provider Network, Featured on Fox Business News, Bulls and Bears with Liz Clayman and David Asman, Revealing Challenge of $3 Million HPN Health Prize, Saving $30 Billion in Health Care Costs 3
(Date:11/26/2014)... November 26, 2014 Increasing incidence ... drug safety regulations are expected to be prime ... Growing prevalence of acute and chronic ailments has ... new drug development. Moreover, growing adverse drug reaction ... same has become the need of the hour ...
(Date:11/26/2014)... November 26, 2014 The city of ... shortages, is moving forward with a plan to recycle ... Radio host Sharon Kleyne supports the San Diego plan ... Management” (TWM). According to Kleyne, by recycling water that ... new water could be greatly reduced. (Spagat, E, “San ...
(Date:11/26/2014)... 2014 With Thousand Oaks cosmetic dental ... prosthodontists at the Anacapa Dental Art Institute in Woodland Hills ... be daunting for some. , That is why they offer ... offer. , “No dentist wants cost to come between a ... said Dr. Mamaly Reshad, partner in the Anacapa Dental Art ...
(Date:11/26/2014)... Schaumburg, IL (PRWEB) November 26, 2014 ... of communication management solutions, has been award the ... Telephony Magazine. , This award comes as a ... its capabilities within the Lync ecosystem. Specifically, ISI ... for all modes of Lync communication, including voice, ...
(Date:11/26/2014)... San Luis Obispo, CA (PRWEB) November 26, 2014 ... bunion treatment, is offering lower prices in an early ... November 26th, Bunion Booties are being offered at the ... Black Friday promotional pricing is in addition to any ... Bootie, visit the Bunion Bootie website for ...
Breaking Medicine News(10 mins):Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2
... finds , , MONDAY, Nov. 3 (HealthDay News) -- Eating ... of kidney disease in people with diabetes, according to ... 517 with diabetes. , The participants, fish consumption was ... who ate less than one serving of fish per ...
... Nov. 3 VirtualScopics, Inc.,(Nasdaq: VSCP ), ... announced today that Ms. Molly Henderson, the company,s ... corporate and,financial overview at two upcoming investor conferences. ... at the Western New York Investors,Conference in Buffalo, ...
... offers available in store during ... American Diabetes Month in November, WOONSOCKET, R.I., ... about managing and,preventing diabetes during American Diabetes Month in November. ... for patients,with diabetes., Nearly 24 million children and adults ...
... prepare for a day without cigarettes and tobacco products ... Smokeout (R) (November 21), new research gives them more ... to the American Academy of Otolaryngology-Head and Neck Surgery ... organization,s annual meeting in September 2008 are studies that ...
... multidisciplinary journal in the neurosciences, Cognitive Computation , ... With this addition to its publishing program, Springer provides ... practices and future trends in the emerging discipline of ... the life sciences, social sciences, engineering, physical and mathematical ...
... Mass., Nov. 3 Culbert Healthcare,Solutions, a ... firm, announced today that Norm Botsford has ... Strategic Services practice., Mr. Botsford recently ... University Physicians Healthcare (UPH), the health system ...
Cached Medicine News:Health News:Fish Twice a Week Cuts Diabetics' Kidney Risks 2Health News:VirtualScopics to Present at Two Upcoming Investor Conferences 2Health News:VirtualScopics to Present at Two Upcoming Investor Conferences 3Health News:CVS/pharmacy Helps Patients Manage Diabetes Care 2Health News:Smokers see decline in ability to smell, rise in laryngitis, and upper airway issues 2Health News:Springer launches Cognitive Computation 2Health News:Norm Botsford Joins Culbert Healthcare Solutions' Strategic Services Team 2
BioSign® Malaria - Rapid Malaria Antigen Test...
Span Diagnostics Limited...
Megakwik Malaria ( P.falciparum ) Card Test...
Malaria ( P. Falciparum ) Whole Blood Strip / Cassette...
Medicine Products: